IOLC 2019 Speakers:
Mike serves as the Oncology Service Line Executive, for Sutter Health - Valley. In his position, Mike directs the strategic, financial and administrative operations for cancer services for the valley region which includes the Bone Marrow Transplant Program in Sacramento and regional infusion centers.
Prior to joining Sutter Health, Mike served six years as the Chief Executive Officer (CEO) for Sarah Cannon Cancer Center Network (78 physicians) with over 16 locations throughout South and Central Texas. Prior experience also includes serving as the Chief Administrative Officer for Aurora Health System for nine years, VP- Specialty Care, Sanford Health for five years and as the Administrative Director- East Region, Henry Ford Health System for four years.
Mike has given many presentations on oncology best practices and reimbursement updates including state and national society meetings. Mike has provided oncology-management consulting both nationally and internationally including the British National Health Service – London and Australian Healthcare Services – Melbourne. In addition, Mike has authored articles on oncology practice management and electronic medical record implementation for national journals including Hematology Oncology News and Issues.
Mike currently serves on the board of directors for the American Cancer Society, Northern California. He has previously served as a board member for March of Dimes, San Antonio, and as a board member and chair of the finance committee for The Wisconsin Conservatory of Music, Milwaukee.
Mike earned his Bachelor’s Degree in Government from The University of Texas at Austin and his Master’s Degree in Business Administration from the Kellogg Program, Northwestern University. In addition, Mike earned his black belt certification in Six Sigma/Lean from The University of Chicago.
Denis Lacombe graduated with his MD from the University of Marseilles (France) in 1988 and obtained a Master Post Doctoral Fellowship at The Roswell Park Cancer Institute (Buffalo, NY USA) for research in pharmacology and pharmacokinetics from 1989 to 1991. From 1991 to 1993, he worked as a Clinical Research Advisor in charge of the development of a new drug in oncology in the pharmaceutical industry.
Dr Lacombe joined the EORTC in 1993 as a research fellow and quickly became a very active and productive Clinical Research Physician involved in the conduct of clinical research from protocol development through publication for a number of oncology indications from phase I to phase III. Dr Lacombe contributed to the strategic evolution of the EORTC pan-European clinical and translational research infrastructure by setting up various supportive assets such as regulatory and pharmacovigilance expertise as well as partnership models with the pharmaceutical industry. Dr Lacombe rose to the position of Director EORTC Headquarters in 2010, and in April 2015 was appointed EORTC Director General. In his current position, Denis Lacombe is now involved in the coordination and administration of all EORTC activities in order to promote the EORTC as a major European organization in Cancer Clinical and Translational Research and is responsible for the organization of scientific activities, public relations and strategies as defined by the EORTC Board as well as for internal and external communications.
Dr Lacombe is the author of well over 104 peer reviewed publications and communications that have had a positive impact on the future of cancer therapy.
Prof. Didier Verhoeven is medical oncologist working in AZ KLINA, Antwerp, Belgium. He was a trainee of Prof. AT. Van Oosterom and is currently Clinical Director of the “Breast Clinic Voorkempen” Dr. D.Verhoeven defended his PhD. thesis : “Tumor cell proliferation and stromal changes in breast cancer” at the University of Antwerp in 1992. In addition he obtained a master degree in medical and pharmaceutical research at the University of Brussels. He wrote many papers especially about breast cancer in peer reviewed journals. He is member of a lot of cancer societies. Although he is a real clinician, part of his work goes to data management and quality improvement. In 2014 he was appointed as guest professor medical oncology (item: quality management) at the University of Antwerp. February 2015 he was the driving force of the 5the International Congress of Breast Disease Centers in Antwerp. He is the leading editor of the book : “Global breast cancer care quality” which will be published by Oxford University Press, end of the year (2019). A faculty of 125 top-experts coming from the five continents and 25 countries worked together to make this a reference book in the field.